Equities research analysts at JPMorgan Chase & Co. started coverage on shares of Ardent Health Partners (NYSE:ARDT – Get Free Report) in a report released on Monday, Briefing.com reports. The brokerage set a “neutral” rating and a $18.00 price target on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 15.09% from the company’s current price.
Other equities analysts have also issued research reports about the company. Mizuho initiated coverage on Ardent Health Partners in a research note on Monday. They issued an “outperform” rating and a $20.00 price objective for the company. Truist Financial started coverage on Ardent Health Partners in a research note on Monday. They issued a “buy” rating and a $21.00 price target for the company. Finally, SVB Leerink began coverage on shares of Ardent Health Partners in a research report on Monday. They set an “outperform” rating and a $23.00 price objective on the stock. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $22.00.
View Our Latest Stock Analysis on ARDT
Ardent Health Partners Stock Performance
Shares of Ardent Health Partners stock opened at $15.64 on Monday. Ardent Health Partners has a fifty-two week low of $15.00 and a fifty-two week high of $18.16.
About Ardent Health Partners
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
See Also
Receive News & Ratings for Ardent Health Partners Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Ardent Health Partners and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
